Skip to main content
JNCI Journal of the National Cancer Institute logoLink to JNCI Journal of the National Cancer Institute
. 2019 Oct 4;112(1):117. doi: 10.1093/jnci/djz186

Corrigendum

PMCID: PMC7850093  PMID: 31584647

Corrigendum to “A Network Meta-Analysis of Surgical Treatment in Patients With Early Breast Cancer. ” by Yu Gui et al. JNCI: J Natl Cancer Inst (2019) 111(9): djz105.

An inconsistency in the Abstract Conclusions of our meta-analysis was found.

Currently the conclusion section says, “M+RT is safer than other surgical regimens for the treatment of early breast cancer patients because of the favorable balance between the survival outcomes. Early breast cancer patients who receive BCS should be given SLNB and not axillary node sampling. Intraoperative RT is no better than postoperative RT in patients who receive SLNB.” Instead, it should be changed to the following: “M+RT has the most favorable survival outcomes among the various surgical regimens for the treatment of early breast cancer patients. For patients who receive BCS, SNLB has more favorable outcomes than axillary node sampling. Intraoperative RT and postoperative RT have similar outcomes in patients who receive SLNB.”

The authors regret the errors.


Articles from JNCI Journal of the National Cancer Institute are provided here courtesy of Oxford University Press

RESOURCES